Cormark Downgrades Curaleaf (OTCMKTS:CURLF) to Hold

Cormark lowered shares of Curaleaf (OTCMKTS:CURLF) from a moderate buy rating to a hold rating in a report released on Thursday morning,Zacks.com reports.

Separately, Needham & Company LLC reiterated a “buy” rating and set a $6.25 price objective on shares of Curaleaf in a report on Thursday, August 8th.

Curaleaf Trading Down 5.5 %

CURLF opened at $2.13 on Thursday. The firm’s fifty day moving average is $2.97 and its two-hundred day moving average is $3.80. The firm has a market cap of $1.38 billion, a PE ratio of -7.34 and a beta of 0.86. Curaleaf has a twelve month low of $2.07 and a twelve month high of $6.40. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.50 and a current ratio of 1.09.

Curaleaf (OTCMKTS:CURLF) last issued its quarterly earnings data on Wednesday, August 7th. The company reported ($0.06) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.01). Curaleaf had a negative return on equity of 13.35% and a negative net margin of 14.82%. The business had revenue of $342.29 million for the quarter, compared to analyst estimates of $344.57 million. Equities research analysts anticipate that Curaleaf will post -0.24 EPS for the current year.

Curaleaf Company Profile

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.